333 related articles for article (PubMed ID: 18719074)
1. Inhibition of ADP-ribosyl cyclase attenuates angiotensin II-induced cardiac hypertrophy.
Gul R; Park JH; Kim SY; Jang KY; Chae JK; Ko JK; Kim UH
Cardiovasc Res; 2009 Feb; 81(3):582-91. PubMed ID: 18719074
[TBL] [Abstract][Full Text] [Related]
2. A novel signaling pathway of ADP-ribosyl cyclase activation by angiotensin II in adult rat cardiomyocytes.
Gul R; Kim SY; Park KH; Kim BJ; Kim SJ; Im MJ; Kim UH
Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H77-88. PubMed ID: 18456728
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanism of ADP-ribosyl cyclase activation in angiotensin II signaling in murine mesangial cells.
Kim SY; Gul R; Rah SY; Kim SH; Park SK; Im MJ; Kwon HJ; Kim UH
Am J Physiol Renal Physiol; 2008 Apr; 294(4):F982-9. PubMed ID: 18272599
[TBL] [Abstract][Full Text] [Related]
4. Discovery of a small-molecule inhibitor for kidney ADP-ribosyl cyclase: Implication for intracellular calcium signal mediated by cyclic ADP-ribose.
Nam TS; Choi SH; Rah SY; Kim SY; Jang W; Im MJ; Kwon HJ; Kim UH
Exp Mol Med; 2006 Dec; 38(6):718-26. PubMed ID: 17202848
[TBL] [Abstract][Full Text] [Related]
5. ADP-ribosyl cyclase couples to cyclic AMP signaling in the cardiomyocytes.
Xie GH; Rah SY; Kim SJ; Nam TS; Ha KC; Chae SW; Im MJ; Kim UH
Biochem Biophys Res Commun; 2005 May; 330(4):1290-8. PubMed ID: 15823583
[TBL] [Abstract][Full Text] [Related]
6. Role of kidney ADP-ribosyl cyclase in diabetic nephropathy.
Kim SY; Park KH; Gul R; Jang KY; Kim UH
Am J Physiol Renal Physiol; 2009 Feb; 296(2):F291-7. PubMed ID: 19073639
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin II Ca2+ signaling in rat afferent arterioles: stimulation of cyclic ADP ribose and IP3 pathways.
Fellner SK; Arendshorst WJ
Am J Physiol Renal Physiol; 2005 Apr; 288(4):F785-91. PubMed ID: 15598842
[TBL] [Abstract][Full Text] [Related]
8. Dopamine D2 receptor stimulation inhibits angiotensin II-induced hypertrophy in cultured neonatal rat ventricular myocytes.
Li H; Shi S; Sun YH; Zhao YJ; Li QF; Li HZ; Wang R; Xu CQ
Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):312-8. PubMed ID: 18986329
[TBL] [Abstract][Full Text] [Related]
9. The expression of messenger RNA for ADP-ribosyl cyclase in aldosterone-producing adenomas.
Takeda Y; Usukura M; Yoneda T; Oda N; Ito Y; Mabuchi H
Clin Endocrinol (Oxf); 2005 Apr; 62(4):504-8. PubMed ID: 15807884
[TBL] [Abstract][Full Text] [Related]
10. Cooperative interaction between reactive oxygen species and Ca2+ signals contributes to angiotensin II-induced hypertrophy in adult rat cardiomyocytes.
Gul R; Shawl AI; Kim SH; Kim UH
Am J Physiol Heart Circ Physiol; 2012 Feb; 302(4):H901-9. PubMed ID: 22140048
[TBL] [Abstract][Full Text] [Related]
11. Nox2-containing NADPH oxidase and Akt activation play a key role in angiotensin II-induced cardiomyocyte hypertrophy.
Hingtgen SD; Tian X; Yang J; Dunlay SM; Peek AS; Wu Y; Sharma RV; Engelhardt JF; Davisson RL
Physiol Genomics; 2006 Aug; 26(3):180-91. PubMed ID: 16670255
[TBL] [Abstract][Full Text] [Related]
12. Erythropoietin attenuates hypertrophy of neonatal rat cardiac myocytes induced by angiotensin-II in vitro.
Wen Y; Zhang XJ; Ma YX; Xu XJ; Hong LF; Lu ZH
Scand J Clin Lab Invest; 2009; 69(4):518-25. PubMed ID: 19347742
[TBL] [Abstract][Full Text] [Related]
13. Growth differentiation factor 15 acts anti-apoptotic and pro-hypertrophic in adult cardiomyocytes.
Heger J; Schiegnitz E; von Waldthausen D; Anwar MM; Piper HM; Euler G
J Cell Physiol; 2010 Jul; 224(1):120-6. PubMed ID: 20232299
[TBL] [Abstract][Full Text] [Related]
14. HMG-CoA reductase inhibitor fluvastatin prevents angiotensin II-induced cardiac hypertrophy via Rho kinase and inhibition of cyclin D1.
Morikawa-Futamatsu K; Adachi S; Maejima Y; Tamamori-Adachi M; Suzuki J; Kitajima S; Ito H; Isobe M
Life Sci; 2006 Aug; 79(14):1380-90. PubMed ID: 16712874
[TBL] [Abstract][Full Text] [Related]
15. DY-9760e inhibits endothelin-1-induced cardiomyocyte hypertrophy through inhibition of CaMKII and ERK activities.
Lu YM; Shioda N; Han F; Kamata A; Shirasaki Y; Qin ZH; Fukunaga K
Cardiovasc Ther; 2009; 27(1):17-27. PubMed ID: 19207476
[TBL] [Abstract][Full Text] [Related]
16. FAK-related nonkinase attenuates hypertrophy induced by angiotensin-II in cultured neonatal rat cardiac myocytes.
Qin J; Liu ZX
Acta Pharmacol Sin; 2006 Sep; 27(9):1159-64. PubMed ID: 16923336
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II receptors subtypes mediate diverse gene expression profile in adult hypertrophic cardiomyocytes.
Zhou J; Xu X; Liu JJ; Lin YX; Gao GD
Clin Exp Pharmacol Physiol; 2007 Nov; 34(11):1191-8. PubMed ID: 17880376
[TBL] [Abstract][Full Text] [Related]
18. Role of cyclic ADP-ribose in Ca2+-induced Ca2+ release and vasoconstriction in small renal arteries.
Teggatz EG; Zhang G; Zhang AY; Yi F; Li N; Zou AP; Li PL
Microvasc Res; 2005 Jul; 70(1-2):65-75. PubMed ID: 16095628
[TBL] [Abstract][Full Text] [Related]
19. Oxytocin-induced elevation of ADP-ribosyl cyclase activity, cyclic ADP-ribose or Ca(2+) concentrations is involved in autoregulation of oxytocin secretion in the hypothalamus and posterior pituitary in male mice.
Lopatina O; Liu HX; Amina S; Hashii M; Higashida H
Neuropharmacology; 2010 Jan; 58(1):50-5. PubMed ID: 19540855
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin II stimulates cyclic ADP-ribose formation in neonatal rat cardiac myocytes.
Higashida H; Zhang J; Hashii M; Shintaku M; Higashida C; Takeda Y
Biochem J; 2000 Nov; 352 Pt 1(Pt 1):197-202. PubMed ID: 11062073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
